Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

J Theruvath, M Menard, BAH Smith, MH Linde… - Nature medicine, 2022 - nature.com
The disialoganglioside GD2 is overexpressed on several solid tumors, and monoclonal
antibodies targeting GD2 have substantially improved outcomes for children with high-risk …
被引用次数：144 相关文章

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

J Theruvath, M Menard, BAH Smith, MH Linde… - paper.sciencenet.cn
The disialoganglioside GD2 is overexpressed on several solid tumors, and monoclonal
antibodies targeting GD2 have substantially improved outcomes for children with high-risk …

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.

J Theruvath, M Menard, B Smith, M Linde… - Nature …, 2022 - escholarship.org
The disialoganglioside GD2 is overexpressed on several solid tumors, and monoclonal
antibodies targeting GD2 have substantially improved outcomes for children with high-risk …

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

J Theruvath, M Menard, BAH Smith… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
The disialoganglioside GD2 is overexpressed on several solid tumors, and monoclonal
antibodies targeting GD2 have substantially improved outcomes for children with high-risk …

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.

J Theruvath, M Menard, BAH Smith, MH Linde… - Nature …, 2022 - europepmc.org
The disialoganglioside GD2 is overexpressed on several solid tumors, and monoclonal
antibodies targeting GD2 have substantially improved outcomes for children with high-risk …
[PDF] google.com

[PDF][PDF] Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

J Theruvath, M Menard, BAH Smith, MH Linde… - Nature …, 2022 - drive.google.com
Results Potent synergy of anti-GD2 and anti-CD47. We first studied the combination of anti-
GD2 and anti-CD47 in neuroblastoma, the only cancer for which anti-GD2 has been …

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

J Theruvath, J Pons, RG Majzner, F Masdeu, E Cesari - Nature Medicine, 2022 - Elsevier
Jaume Pons | ScienceDirect Skip to main content Elsevier logo Journals & Books Search
RegisterSign in Jaume Pons Author information Author information Current affiliation: Universitat …
[HTML] nih.gov

[HTML][HTML] Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

J Theruvath, M Menard, BAH Smith, MH Linde… - Nature …, 2022 - ncbi.nlm.nih.gov
The disialoganglioside GD2 is overexpressed on several solid tumors, and monoclonal
antibodies targeting GD2 have substantially improved outcomes for children with high-risk …

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.

J Theruvath, M Menard, BAH Smith, MH Linde… - Nature …, 2022 - europepmc.org
The disialoganglioside GD2 is overexpressed on several solid tumors, and monoclonal
antibodies targeting GD2 have substantially improved outcomes for children with high-risk …